This inventor holds 1 USPTO granted patent. Top assignee: Bracco Research Sa. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Agnès Hiver: Innovator in Biologically Active Substance Delivery
Introduction
Agnès Hiver is a notable inventor based in Clarafond, France. He has made significant contributions to the field of medical technology, particularly in the delivery of biologically active substances to targeted sites within the human body. His innovative methods have the potential to enhance the efficacy of treatments and diagnostics.
Latest Patents
Agnès Hiver holds a patent for a method titled "Delivery of biologically active substance to target sites in the body of patients." This invention focuses on a technique for administering bioactive substances to patients at specific locations within the body. The method involves creating an administrable formulation that includes liposomes filled with bioactive substances and gas-filled microspheres. By injecting this formulation into a patient's circulation and applying ultrasound pulses, the gas-filled microbodies can explode, allowing the liposomes to release their contents at the desired site. This innovative approach also includes formulations available in kit form, which comprise sterile precursor components.
Career Highlights
Agnès Hiver is associated with Bracco Research SA, where he continues to develop and refine his groundbreaking methods. His work has garnered attention for its potential applications in both therapeutic and diagnostic fields.
Collaborations
Agnès has collaborated with notable colleagues, including Michel Schneider and Feng Yan, who have contributed to his research and development efforts.
Conclusion
Agnès Hiver's innovative work in the delivery of biologically active substances represents a significant advancement in medical technology. His patented methods have the potential to improve patient outcomes through targeted treatment strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
